Dan Feng

Dan Feng practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dan Feng's NPI, 1619408374, was assigned on March 24, 2017. Dan Feng graduated from Stanford University School Of Medicine in 2017. Dan Feng holds New York license 297750.

Dan Feng's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dan Feng also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dan Feng's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dan Feng to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dan Feng practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dan Feng's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dan Feng is licensed in New York.

CMS data shows 168 Medicare services from Dan Feng across 2 procedure codes in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $20,979 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dan Feng in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dan Feng's median patient age at 67, with 36% women.

In 2024, Dan Feng wrote 169 Medicare Part D claims for 30 patients. 91% of them were for generic drugs. CMS names the drug for 60 of them, across 4 drugs with 11 or more claims each, at $710 in total drug cost.

Dan Feng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dan Feng as offering telehealth.

Dmand AI links 41 papers to Dan Feng, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Models, Molecular, Liver and Mice, Inbred C57BL. Dan Feng has published most often in Nature. Dan Feng's most frequent co-authors are Mitchell A. Lazar, MD, Tong S. Kobilka, MD and Jeffrey Tarrasch, MD.

CMS Open Payments shows 17 general payments to Dan Feng from 8 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $8,966. It also lists 3 research payments totaling $209 in 2025.

Dan Feng graduated from Stanford University School Of Medicine in 2017.